Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 70

1.

Animal models of nicotine exposure: relevance to second-hand smoking, electronic cigarette use, and compulsive smoking.

Cohen A, George O.

Front Psychiatry. 2013 Jun 4;4:41. doi: 10.3389/fpsyt.2013.00041. eCollection 2013.

2.

Robust escalation of nicotine intake with extended access to nicotine self-administration and intermittent periods of abstinence.

Cohen A, Koob GF, George O.

Neuropsychopharmacology. 2012 Aug;37(9):2153-60. doi: 10.1038/npp.2012.67. Epub 2012 May 2.

3.

Animal models of nicotine withdrawal: intracranial self-stimulation and somatic signs of withdrawal.

Bauzo RM, Bruijnzeel AW.

Methods Mol Biol. 2012;829:257-68. doi: 10.1007/978-1-61779-458-2_16.

PMID:
22231819
4.

Neurobiology of the nicotine withdrawal syndrome.

Kenny PJ, Markou A.

Pharmacol Biochem Behav. 2001 Dec;70(4):531-49. Review.

PMID:
11796152
5.

[Smoking reduction and temporary abstinence: new approaches for smoking cessation].

Le Houezec J, Säwe U.

J Mal Vasc. 2003 Dec;28(5):293-300. Review. French.

PMID:
14978435
6.

Exposure to chronic intermittent nicotine vapor induces nicotine dependence.

George O, Grieder TE, Cole M, Koob GF.

Pharmacol Biochem Behav. 2010 Jul;96(1):104-7. doi: 10.1016/j.pbb.2010.04.013. Epub 2010 Apr 24.

7.

Nicotine addiction: insights from recent animal studies.

Mathieu-Kia AM, Kellogg SH, Butelman ER, Kreek MJ.

Psychopharmacology (Berl). 2002 Jul;162(2):102-18. Epub 2002 May 15. Review.

PMID:
12110988
8.

Tobacco smoke exposure induces nicotine dependence in rats.

Small E, Shah HP, Davenport JJ, Geier JE, Yavarovich KR, Yamada H, Sabarinath SN, Derendorf H, Pauly JR, Gold MS, Bruijnzeel AW.

Psychopharmacology (Berl). 2010 Jan;208(1):143-58. doi: 10.1007/s00213-009-1716-z. Epub 2009 Nov 21.

9.

Nicotine as a typical drug of abuse in experimental animals and humans.

Le Foll B, Goldberg SR.

Psychopharmacology (Berl). 2006 Mar;184(3-4):367-81. Epub 2005 Oct 5.

PMID:
16205918
10.
11.

Nicotine replacement therapy.

Thompson GH, Hunter DA.

Ann Pharmacother. 1998 Oct;32(10):1067-75. Review.

PMID:
9793600
12.
13.

Neuropharmacology of cocaine and ethanol dependence.

Koob GF, Weiss F.

Recent Dev Alcohol. 1992;10:201-33. Review.

PMID:
1350359
14.

Human tobacco smokers in early abstinence have higher levels of beta2* nicotinic acetylcholine receptors than nonsmokers.

Staley JK, Krishnan-Sarin S, Cosgrove KP, Krantzler E, Frohlich E, Perry E, Dubin JA, Estok K, Brenner E, Baldwin RM, Tamagnan GD, Seibyl JP, Jatlow P, Picciotto MR, London ED, O'Malley S, van Dyck CH.

J Neurosci. 2006 Aug 23;26(34):8707-14.

15.

Pharmacologic Determinants of Tobacco Dependence.

Schuh LM, Schuh KJ, Henningfield JE.

Am J Ther. 1996 May;3(5):335-341.

PMID:
11862269
16.

Nicotine replacement therapy for smoking cessation.

Stead LF, Perera R, Bullen C, Mant D, Hartmann-Boyce J, Cahill K, Lancaster T.

Cochrane Database Syst Rev. 2012 Nov 14;11:CD000146. doi: 10.1002/14651858.CD000146.pub4. Review.

PMID:
23152200
17.
18.

Quitting cigarette smoking produces minimal loss of chronic tolerance to nicotine.

Perkins KA, Gerlach D, Broge M, Sanders M, Grobe J, Fonte C, Cherry C, Wilson A, Jacob R.

Psychopharmacology (Berl). 2001 Oct;158(1):7-17.

PMID:
11685379
19.
20.

Modeling nicotine addiction in rats.

Caille S, Clemens K, Stinus L, Cador M.

Methods Mol Biol. 2012;829:243-56. doi: 10.1007/978-1-61779-458-2_15. Review.

PMID:
22231818
Items per page

Supplemental Content

Write to the Help Desk